title: Acute hepatitis E during biotherapy.
abstract: Hepatitis E is a rare and usually asymptomatic infection. However, its incidence is rising in France, and it can cause severe or chronic manifestations in immunocompromised patients. Here, we report a case of hepatitis E in a patient with rheumatoid arthritis who had immunosuppression due to treatment with a biological agent.
authors.affiliation: Internal medicine E and rheumatology department, hôpitaux civils de Colmar, 39, avenue de la Liberté, 68000 Colmar, France.
authors.forename: Hélène
authors.initials: H
authors.lastname: Bauer
authors.forename: Jean
authors.initials: J
authors.lastname: Sibilia
authors.forename: Paul
authors.initials: P
authors.lastname: Moreau
authors.forename: Laurent
authors.initials: L
authors.lastname: Messer
mesh_terms: D000069594:Abatacept; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D016751:Hepatitis E / Q000139:chemically induced / Q000209:etiology / Q000628:therapy*; D006801:Humans; D016867:Immunocompromised Host; D018796:Immunoconjugates / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept